This bill would reauthorize the National All Schedules Prescription Electronic Reporting Act (NASPER), which gives grants to states to monitor prescription drug use. NASPER funding allows healthcare providers, regulators, state licensing agencies, and law enforcement to monitor and track prescription drug information to prevent and stop abuse.
The NASPER program would be reauthorized through fiscal year 2020 to:
Give grant funding to maintain and operate existing state controlled substance monitoring programs;
Require the Dept. of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees;
Require a state to give HHS aggregate data and other information to help HHS evaluate the effectiveness of the state’s program;
Expand the program to include commonwealths and territories of the U.S.
NASPER grants would be provided through the Substance Abuse and Mental Health Services Administration (SAMHSA) to establish, implement, and improve prescription drug monitoring programs (PDMPs). PDMPs help providers access accurate prescription information, and screen patients who are at risk for addiction so they can receive alternative treatment if necessary.
States receiving these grants would have to bring prescribers and dispensers up to speed on the state’s controlled substance monitoring system. States would also have to teach prescribers and dispensers the benefits of the system to them and society.